NANOVAC
Latest Information Update: 28 Feb 2026
At a glance
- Originator Intravacc; Leiden University Medical Center
- Class Adjuvants; COVID-19 vaccines; Peptide vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Coronavirus infections; COVID 2019 infections
Most Recent Events
- 28 Feb 2026 No recent reports of development identified for preclinical development in COVID-2019-infections(Prevention) in Netherlands (Intranasal, Spray)
- 28 Feb 2026 No recent reports of development identified for research development in Coronavirus-infections(Prevention) in Netherlands (Intranasal, Spray)
- 05 Jan 2022 Early research in Coronavirus infections (Prevention) in Netherlands (Intranasal) as of January 2022